|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Octapharma will sponsor two satellite symposia at the upcoming ISBT Congress, June 7 - 12, 2008 in Macau SAR, China
May 27, 2008
Octapharma at WFH Congress, June 1 - 5, 2008, Istanbul, Turkey
May 24, 2008
Octapharma acquisition of a plasma fractionation plant in Springe, Germany from German Red Cross organizations
May 8, 2008
Welcome to Octapharma!
Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.
The information provided on the Octapharma website is based on world-wide business and approved international product specifications. As registration status and prescribing information for our products vary from country to country, you are encouraged to contact your local Octapharma office for country specific information. In addition, Octapharma is developing specific country web pages which may also be referenced. US residents, for example, should refer to Octapharma USA on the pull down list below for FDA approved product information:
Last update 5/27/2008, © Octapharma AG |
|
 |
|
|
|
